Multidrug resistance in yeast Candida

International Review of Cytology

Volumn 242, Issue , 2004, Pages 215-248

  Prasad, Rajendra ^a   Kapoor, Khyati ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

ABC transporter; Azoles; Candida; Efflux pumps; Ergosterol; MFS transporters; Multidrug resistance

Indexed keywords

1,10 PHENANTHROLINE; 2,4 DINITROPHENOL; ALLYLAMINE DERIVATIVE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ASCOMYCIN; BREFELDIN A; CERULENIN; CHLORAMPHENICOL; CORTICOSTERONE; CYCLOHEXIMIDE; ECHINOCANDIN B; ERYTHROMYCIN; ESTRADIOL; FLUCONAZOLE; FLUCYTOSINE; FLUPHENAZINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; OLIGOMYCIN; POLYENE ANTIBIOTIC AGENT; PYRIMIDINE DERIVATIVE; PYRROLE; RHODAMINE 123; RHODAMINE 6G; TACROLIMUS; TERBINAFINE; UNINDEXED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; CANDIDA; CANDIDIASIS; DRUG BINDING; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TARGETING; FUNGAL STRAIN; GENE EXPRESSION; HUMAN; LIPID COMPOSITION; MITOCHONDRIAL RESPIRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; YEAST;

CANDIDA; CANDIDA ALBICANS;

EID: 10444285332     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(04)42005-1     Document Type: Article

References (148)

1. Aoki S., Ito-Kuwo S., Nakamura Y., Masuhara T. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zentralbl. Bakteriol. 273:1990;332-343
2. Arie Z.R., Altboum Z., Sandovsky-Losica H., Segal E. Adhesion of Candida albicans mutant strains to host tissue. FEMS Microbiol. Lett. 163:1998;121-127
3. Azzaria M., Schurr E., Gros P. Discrete mutations introduced in the predicted nucleotide-binding site of the mdr1 gene abolish its ability to confer multidrug resistance. Mol. Cell. Biol. 9:1989;5289-5297
4. Balan I., Alarco A.M., Raymond M. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter. J. Bacteriol. 179:1997;7210-7218
5. Balkis M.M., Leidich S.D., Mukherjee P.K., Ghannoum M.A. Mechanism of fungal resistance. Drugs. 62:2002;1025-1040
6. Barchiesi F., Calabrese D., Sanglard D., Falconi Di Francesco L., Caselli F., Giannini D., Giacometti A., Gavaudan S., Scalise D. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44:2000;1578-1584
7. Becker J.M., Henry L.K., Jiang W., Koltin Y. Reduced virulence of Candida albicans mutants affected in drug resistance. Infect. Immun. 63:1995;4515-4518
8. Bennett J.E., Izumikawa K., Marr K.A. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother. 48:2004;1773-1777
9. Ben-Yaacov R., Knoller S., Caldwell G.A., Becker J.M., Koltin Y. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:1994;648-652
10. Brinkmann U., Eichelbaum M. Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenom. J. 1:2001;59-64
11. Brun S., Aubry C., Lima O., Filmon R., Berges T., Chabasse D., Bouchara J.P. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 47:2003;847-853
12. Brun S., Berges T., Poupard P., Vauzelle-Moreau C., Renier G., Chabasse D., Bouchara J.P. Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob. Agents Chemother. 48:2004;1788-1796
13. Calabrese D., Bille J., Sanglard D. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology. 146:2000;2743-2754
14. Cannon R.D., Tsao S., Ong S., Niimi K., Lamping E., Monk B.C., Holmes A.R. Allelic variation affecting drug pump function in Candida albicans. ASM Conference on Candida and Candidiasis, abstract no. 147(C). March 18-22, Austin, TX:2004
15. Cascorbi I., Gerloff T., Johne A., Christian M., Hoffmeyer S., Schwab M., Schaeffeler E., Eichelbaum M., Brinkmann U. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther. 69:2001;169-174
16. Chamberland S., Blais J., Cotter D.P. Impact of MC510,027, a fungal efflux pump inhibitor, on the susceptibility of clinical isolates of Candida spp. to antifungal agents. Proceedings of Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract no. 1270. September 26-29, 1999, San Francisco, CA:1999
17. Coleman D.C., Rinaldi M.G., Haynes K.A., Rex J.H., Summerbell R.C., Anaissie E., Li A., Sullivan D.J. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36:1998;156-165
18. Cruz M.C., Goldstein A.L., Blankenship J.R., Poeta M.D., Davis D., Cardenas M.E., Perfect J.R., McCusker J.H., Heitman J. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:2002;546-559
19. Cuenca-Estrella M., Diaz-Guerra T.M., Mellado E., Rodriguez-Tudela J.L. Flucytosine primary resistance in Candida species and Cryptococcus neoformans. Eur. J. Clin. Microbiol. Infect. Dis. 20:2001;276-279
20. De Backer M.D., Ilyina T., Ma X-J., Vandoninck S., Luyten W.H., Vanden Bossche H. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:2001;1660-1670
21. Demeule M., Jodoin J., Gingras D., Beliveau R. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466:2000;219-224
22. Dogra S., Krishnamurthy S., Gupta V., Dixit B.L., Gupta C.M., Sanglard D., Prasad R. Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast. 15:1999;111-121
23. Edlind T.D., Smith L., Henry K. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signaling. Mol. Microbiol. 46:2002;257-268
24. Egner R., Rosenthal F.E., Kralli A., Sanglard D., Kuchler K. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol. Biol. Cell. 9:1998;523-543
25. Egner R., Bauer B.E., Kuchler K. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. Mol. Microbiol. 35:2000;1255-1263
26. Emter R., Hesse-Peck A., Kralli A. ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms. FEBS Lett. 521:2002;57-61
27. Favre B., Didmon M., Ryder N.S. Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans. Microbiology. 145:1999;2715-2725
28. Ferte J. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267:2000;277-294
29. Fling M.E., Kopf J., Tamarkin A., Gorman J.A., Smith H.A., Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:1991;318-329
30. Franz R., Michel S., Morschhauser J. A fourth gene from the Candida albicans CDR family of ABC transporters. Gene. 220:1998;91-98
31. Gauthier C., Weber S., Alarco A-M., Alqawi O., Daoud R., Georges E., Raymond M. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob. Agents Chemother. 47:2003;1543-1554
32. Ghannoum M., Rice L.B. Antifungal agents, mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:1999;501-512
33. Graham-Lorence S., Peterson J.A. P450s, structural similarities and functional differences. FASEB J. 10:1996;206-214
34. Gupta V., Kohli A.K., Krishnamurthy S., Puri N., Aalamgeer S.A., Panwar S.L., Prasad R. Identification of mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance and its in vitro transcriptional activation. Curr. Genet. 34:1998;192-199
35. Harry J.B., Song J.L., Lyons C.N., White T.C. Transcription initiation of genes associated with azole resistance in Candida albicans. Med. Mycol. 40:2002;73-81
36. Hitchcock C.A. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1993;1039-1047
37. Hitchcock C.A., Pye G.W., Troke P.F., et al. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1993;1962-1965
38. Hoffmeyer S., Burk O., Von Richter H.P., Arnold H.P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene, multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA. 97:2000;3473-3478
39. Jandourek A., Brown P., Vazquez J.A. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Clin. Infec. Dis. 29:1999;1583-1584
40. Jha S., Karnani N., Dhar S.K., Mukhopadhayay K., Shukla S., Saini P., Mukhopadhayay G., Prasad R. Purification and characterization of N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans, uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. Biochemistry. 42:2003a;10822-10832
41. Jha S., Karnani N., Lynn A.M., Prasad R. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of Candida drug efflux pump. Biochem. Biophys. Res. Commun. 310:2003b;869-875
42. Jha S., Dabas N., Karnani N., Saini P., Prasad R. ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide binding domains which display functional asymmetry. FEMS Yeast Res. 5:2004;63-72
43. Kakeya H., Miyazaki Y., Miyazaki H., Nyswaner K., Grimberg B., Bennett J.E. Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob. Agents Chemother. 44:2000;2985-2990
44. Kappeli O. Cytochromes P-450 of yeasts. Microbiol. Rev. 50:1986;244-258
45. Katiyar S.K., Edlind T.D. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med. Mycol. 39:2001;109-116
46. Kaur R., Bachhawat A.K. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiology. 145:1999;809-818
47. Kaur R., Castano I., Cormack B.P. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata, roles of calcium signaling and mitochondria. Antimicrob. Agents Chemother. 48:2004;1600-1613
48. 5,6-desaturation. FEBS Lett. 400:1997a;80-82
49. 22- desaturase, and inhibition by azole antifungal agents. J. Biol. Chem. 272:1997b;9986-9988
50. Kelly S.L., Lamb D.C., Juergen L., Einsele H., Kelly D.E. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem. Biophys. Res. Commun. 262:1999;174-179
51. Kontoyiannis D.P. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae. J. Antimicrob. Chemother. 46:2000;191-197
52. Krishnamurthy S., Chatterjee U., Gupta V., Prasad R., Das P., Snehlata P., Hasnain S.E., Prasad R. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: Expression of a yeast multidrug transporter in baculovirus expression system. Yeast. 14:1998;535-550
53. Krishnamurthy S., Plaine A., Albert J., Prasad T., Prasad R., Ernst J.F. Dosage-dependent functions of fatty acid desaturase O1e1p in growth and morphogenesis of Candida albicans. Microbiology. 150:2004;1991-2003
54. Kusch H., Biswas K., Schwanfelder S., Engelmann S., Rogers P.D., Hecker M., Morschhauser J. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol. Genet. Genom. 271:2004;554-565
55. Lamb D.C., Kelly D.E., Schunck W-H., Shyadehi A.Z., Akhtar M., Lowe D.J., Baldwin B.C., Kelly S.L. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J. Biol. Chem. 272:1997;5682-5688
56. 22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob. Agents Chemother. 43:1999;1725-1728
57. Lamb D.C., Kelly D.E., White T.C., Kelly S.L. The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity. Antimicrob. Agents Chemother. 44:2000;63-67
58. Lavie Y., Liscovitch M. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistance cancer cells and their functional consequences. Glycoconj. J. 17:2001;253-259
59. Lavie Y., Fiucci G., Liscovitch M. Up-regulation of caveolae and caveolar constituents in multi-drug-resistant cancer cells. J. Biol. Chem. 273:1998;32380-32383
60. Liscovitch M., Lavie Y. Multidrug resistance, a role for cholesterol efflux pathways? Trends. Biochem. Sci. 25:2000;530-537
61. Loffler J., Kelly S.L., Hebart H., Schumacher U., Lass-Florl C., Einsele H. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains. FEMS Microbiol. Lett. 151:1997;263-268
62. Loffler J., Einsele H., Hebart H., Schumacher U., Hrastnik C, Daum G. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol. Lett. 185:2000;59-63
63. Loo T.W., Clarke D.M. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:1993;19965-19972
64. Loo T.W., Clarke D.M. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. J. Biol. Chem. 269:1994a;7243-7248
65. Loo T.W., Clarke D.M. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:1994b;3143-3149
66. Loo T.W., Clark D.M. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J. Biol. Chem. 270:1995a;22957-22961
67. Loo T.W., Clark D.M. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. J. Biol. Chem. 270:1995b;21449-21452
68. Luker G.D., Pica C.M., Kumar A.S., Covey D.F., Piwnica-Worms D. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry. 39:2000;7051-7661
69. Maesaki S., Marichal P., Hossain M.A., Sanglard D., Bossche H.V., Kohno S. Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 42:1998;747-753
70. Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob. Agents Chemother. 44:2001;2373-2381
71. Marchetti O., Moreillon P., Entenza J.M., Vouillamoz J., Glauser M.P., Bille J., Sanglard D. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob. Agents Chemother. 47:2003;1565-1570
72. Marichal P. Mechanisms of resistance to azole antifungal compounds. Curr. Opin. Anti-infect. Invest. Drugs. 1:1999;318-333
73. Marichal P., Vanden Bossche H., Odds F.C., Nobels G., Warnock D.W., Timmerman V., Van Broeckhoven C., Fay S., Mose-Larsen P. Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 41:1997;2229-2237
74. Marichal P., Koymans L., Willemsens S., Bellens D., Verhasselt P., Luyten W., Borgers M., Ramaekers F.C.S., Odds F.C., Vanden Bossche H. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology. 145:1999;2701-2713
75. Martin M.V., Dinsdale R.C. Nystatin-resistance of Candida albicans isolates from two cases of oral candidiasis. Br. J. Oral Surg. 20:1982;294-298
76. Martin S.W., Konopka J.B. Lipid rafts polarization contributes to hyphal growth in Candida albicans. Eukaryot. Cell. 3:2004;675-684
77. Mas J., Pina E. Disappearance of nystatin resistance in Candida mediated by ergosterol. J. Gen. Microbiol. 117:1980;249-252
78. Miyazaki H., Miyazaki Y., Geber A., Parkinson T., Hitchcock C., Falconer D.J., Ward D.J., Marsden K., Bennett J.E. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42:1998;1695-1701
79. Moran G.P., Sanglard D., Donnelly S.M., Shanley D.B., Sullivan D.J., Coleman D.C. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1998;1819-1830
80. Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta. 1587:2002;240-248
81. Mukhopadhyay K., Kohli A.K., Prasad R. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46:2002;3695-3705
82. Mukhopadhyay K., Prasad T., Saini P., Pucadyil T.J., Chattopadhyay A., Prasad R. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob. Agents Chemother. 48:2004;1778-1787
83. Nascimento A.M., Goldman G.H., Park S., Marras S.A.E., Delmas G., Oza U., Lolans K., Dudley M.N., Mann P.A., Perlin D.S. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47:2003;1719-1726
84. Nebert D.W., Gonzalez F.J. P450 genes, structure, evolution, and regulation. Annu. Rev. Biochem. 56:1987;945-993
85. Niimi K., Harding D.R., Parshot R., King A., Lun D.J., Decottignies A., Niimi M., Lin S., Cannon R.D., Goffeau A., Monk B.C. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob. Agents Chemother. 48:2004;1256-1271
86. Ogawa A., Hashida-Okado T., Endo M., Yoshioka H., Tsuruo T., Takesako K., Kato I. Role of ABC transporters in aureobasidin A resistance. Antimicrob. Agents Chemother. 42:1998;755-761
87. Ohkuma M., Muraoka S-I., Tanimoto T., Fujii M., Ohta A., Takagi M. CYP52 (cytochrome P450alk) multigene family in Candida maltosa Identification and characterization of eight members. DNA Cell Biol. 14:1995;163-173
88. Onyewu C., Blankenship J.R., Poeta M.D., Heitman J. Ergosterol biosynthesis inhibitors become fungicigal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata and Candida krusei. Antimicrob. Agents Chemother. 47:2003;956-964
89. Orozco A.S., Higginbotham L.M., Hitchcock C.A., Parkinson T., Falconer D., Ibrahim A.S., Ghannoum M.A., Filler S.G. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42:1998;2645-2649
90. Pajeva I.K., Globisch C., Weise M. Structure-function relationships of multidrug resistance P-glycoprotein. J. Med. Chem. 47:2004;2523-2533
91. Panwar S.L., Krishnamurthy S., Gupta V., Alarco A.M., Raymond M., Sanglard D., Prasad R. CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans. Yeast. 18:2001;1117-1129
92. Paulsen I.T., Brown M.H., Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:1996;575-608
93. Perea S., Lopez-Ribot J.L., Kirkpatrick W.R., McAtee R.K., Santillan R.A., Martinez M., Calabrese D., Sanglard D., Patterson T.F. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2001;2676-2684
94. Pfaller M.A., Messer S.A., Boyken L., Huynh H., Hollis R.J., Diekema D.J. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: Global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46:2002;3518-3521
95. Pinjon E., Moran G.P., Jackson C.J., Kelly S.L., Sanglard D., Coleman D.C., Sullivan D.J. Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47:2003;2424-2437
96. Posteraro B., Sanguinetti M., Sanglard D., La Sorda M., Boccia S., Romano L., Morace G., Fadda G. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol. Microbiol. 47:2003;357-371
97. Prasad R., Worgifosse P.D., Goffeau A., Balzi E. Molecular cloning and characterization of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:1995;320-329
98. Prasad R., Panwar S.L., Krishnamurthy S. Drug resistance mechanisms of human pathogenic fungi. Calderone R.A., Cihlar R.L. "Fungal Pathogenesis: Principles and Clinical Applications" 2000;601-631 Marcel Dekker, New York
99. Raymond M., Dignard D., Alarco A.M., Mainville N., Magee B.B., Thomas D.Y. A Ste6pP-glycoprotein homologue from the asexual yeast Candida albicans transports the a-factor mating pheromone in Saccharomyces cerevisiae. Mol. Microbiol. 27:1998;587-598
100. Redding S.J., Smith J., Farinacci G., Rinaldi M., Fothergill A., Rhine-Chalberg J., Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS, documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:1994;240-242
101. Redding S.W., Kirkpatrick W.R., Saville S., Coco B.J., White W., Fothergill A., Rinaldi M., Eng T., Patterson T.F., Lopez-Ribot J. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41:2003;619-622
102. Rogers P.D., Barker K.S. Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA analysis. Antimicrob. Agents Chemother. 46:2002;3412-3417
103. Rogers P.D., Barker K.S. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47:2003;1220-1227
104. Roth-Ben A.Z., Altboum Z., Berdicevsky I., Segal E. Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia. 141:1998;127-135
105. Safe L.M., Safe S.H., Subden R.E., Morris D.C. Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. Can. J. Microbiol. 23:1977;398-401
106. Saier M.H. Jr., Reizer J. Families and super families of transport proteins common to prokaryotes and eukaryotes. Curr. Opinion Struct. Biol. 1:1991;362-368
107. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:1995;2378-2386
108. Sanglard D., Ischer F., Monod M., Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents, Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology. 143:1997;405-416
109. Sanglard D., Ischer F., Koymans L. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42:1998a;241-255
110. Sanglard D., Ischer F., Calabrese D., de Micheli M., Bille J. Multiple resistance mechanism to azole antifungals in yeast clinical isolates. Drug Resist. Updates. 1:1998b;255-265
111. Sanglard D., Ischer F., Bille J. The role of the ATP binding cassette (ABC)-transporter genes CgCDR1 and CgCDR2 in the resistance of Candida glabrata to azole antifungals. ASM Conference on Candida and Candidiasis, abstract no. C25. March 1-4, 1999, Charleston, SC:1999
112. Sanglard D., Ischer F., Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45:2001;1174-1183
113. Scholer H.J., Polak A. Resistance to systemic antifungal agents in antimicrobial drug resistance. Bryan L. "Antimicrobial Drug Resistance" 1984;393-460 Academic Press, Orlando, FL
114. Schuetzer-Muehlbauer M., Willinger B., Egner R., Ecker G., Kuchler K. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int. J. Antimicrob. Agents. 22:2003a;291-300
115. Schuetzer-Muehlbauer M., Willinger B., Krapf G., Enzinger S., Presterl E., Kuchler K. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin. Mol. Microbiol. 48:2003b;225-235
116. Seghezzi W., Meili C., Ruffiner R., Kuenzi R., Sanglard D., Fiechter A. Identification and characterization of additional members of the cytochrome P450 multigene family CYP52 of Candida tropicalis. DNA Cell Biol. 11:1992;767-780
117. Semighini C.P., Marins M., Goldman M.H., Goldman G.H. Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by real-time reverse transcription-PCR assay. Appl. Environ. Microbiol. 68:2002;1351-1357
118. Shukla S., Saini P., Smriti, Jha S., Ambudkar S.V., Prasad R. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell. 2:2003;1361-1375
119. Shukla S., Ambudkar S.V., Prasad R. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. J. Antimicrob. Chemother. 54:2004;38-45
120. Shukla S., Sauna Z.E., Prasad R., Ambudkar S.V. Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans. Biochem. Biophys. Res. Commun. 322:2004;520-525
121. Slaven J.W., Anderson M.J., Sanglard D., Dixon G.K., Bille J., Roberts I.S., Denning D.W. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet. Biol. 36:2002;199-206
122. Smriti, Krishnamurthy S., Dixit B.L., Gupta C.M., Milewski S., Prasad R. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast. 19:2002;303-318
123. Stark G.R., Wahl G.M. Gene amplification. Annu. Rev. Biochem. 53:1984;447-491
124. Sterling T.R., Gasser R.A.J., Ziegler A. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin. Infect. Dis. 23:1996;187-188
125. Sternberg S. The emerging fungal threat. Science. 266:1994;1632-1634
126. St-Gremain G., Laverdiere M., Pelletier R., Bourgault A.M., Libman M., Lemieux C., Noel G. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites, results of a 2-year (1996 to 1998) multicenter survillance study in Quebec, Canada. J. Clin. Microbiol. 39:2001;949-953
127. Theiss S., Agabian N., Kohler G. Molecular characterization of a new ATP-dependent transporter in Candida albicans. ASM Conference on Candida and Candidiasis, abstract no. C29. March 1-4, 1999, Charleston, SC. ASM Conference on Candida and Candidiasis, abstract no. C25. March 1-4, 1999, Charleston, SC:1999
128. Thornewell S.J., Peery R.B., Skatrud P.L. Cloning and characterization of CneMDR1, a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene. 201:1997;21-29
129. Tobin M.B., Peery R.B., Skatrud P.L. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. Gene. 200:1997;11-23
130. Vanden Bossche H. Chemotherapy of human fungal infections. Lyr H. "Modern Selective Fungicides: Properties, Applications, Mechanisms of Action" 1995;431-484 Gustav Fisher Verlag, Jena, Germany
131. Vanden Bossche H., Koymans L. Cytochromes P450 in fungi. Mycoses. 41:1998;32-38
132. Vanden Bossche H., Marichal P., Gorrens J., Coene M.C., Willemsens G., Bellens D., Roels I., Moereels H., Janssen P.A.J. Biochemical approaches to selective antifungal activity, focus on azole antifungals. Mycoses. 32:1989;35-52
133. Vanden Bossche H., Marichal P., Odds F.C., Le Jeune L., Coene M.C. Characterization of an azole resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:1992;2602-2610
134. Vanden Bossche H., Marichal P., Odds F.C. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:1994a;393-400
135. Vanden Bossche H., Warnock D.G., Dupont B., Kerridge D., Sengupta S., Improvisi L., Marichal P., Odds F.C., Provost F., Ronin O. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32:1994b;189-202
136. Van Den Hazel H.B., Pichler H., Do Valle Matta M.A., Leitner E., Goffeau A., Daum G. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J. Biol. Chem. 274:1999;1934-1941
137. Van der Bleik A.M., Baas F., Van der Velde-Koerts T., Biedler J.L., Meyers M.B., Ozols R.F., Hamilton T.C., Joenje H., Borst P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 48:1988;5927-5932
138. Venkateswarlu K., Denning D.W., Manning N.J., Kelly S.L. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance. Antimicrob. Agents Chemother. 40:1996;2443-2446
139. Wada S., Niimi M., Niimi K., Holmes A.R., Monk B.C., Cannon R.D., Uehara Y. Candida glabrata ATP-binding cassette transporter Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation dependent pumping properties. J. Biol. Chem. 277:2002;46809-46821
140. White T.C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1997a;1482-1487
141. White T.C. Antifungal drug resistance in Candida albicans. ASM News. 63:1997b;427-433
142. White T.C. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α-demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1997c;1488-1494
143. White T.C., Marr K.A., Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:1998;382-402
144. White T.C., Holleman S., Dy F., Mirels L.F., Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:2002;1704-1713
145. Wilkinson C.F., Hetnarski K., Yellin T.O. Imidazole derivatives - a new class of microsomal enzyme inhibitors. Biochem. Phamacol. 21:1972;3187-3192
146. Wilkinson C.F., Hetnarski K., Hicks L.J. Substituted imidazoles as inhibitors of microsomal oxidation and insecticide synergists. Pestic. Biochem. Physiol. 4:1974;299-312
147. Woodahl E.L., Ho R.J. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function. Curr. Drug Metab. 5:2004;11-19
148. Xiao L., Madison V., Chau A.S., Loebenberg D., Palermo R.E., McNicholas P.M. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:2004;568-574